Animal rule for drug approval creates a jungle of confusion | WHO recommends new B strain for next season’s flu vaccine | Contract approved for utility plant to serve biodefense lab | New device better traps viruses, airborne pathogens | 3rd Intelligence Battalion sharpens CBRN skills | Biological warfare biggest threat to world today | Although well-adapted, novel coronavirus susceptible to immunotherapy | Influenza vaccine efficacy: as low as 31%? | Stash of stem cells found in a human parasite | Defusing the threat of ionizing radiation | Los Angeles health officials concerned about TB outbreak | FDA expert: Universal flu vaccine still 5-10 years off | Quintiles files with SEC to become public company | Ancient teeth bacteria record disease evolution
See what we’re reading this week at Global Biodefense on topics like universal flu vaccine timeline, TB outbreak in LA, ionizing radiation countermeasures and more…
Animal rule for drug approval creates a jungle of confusion (Nature)
WHO recommends new B strain for next season’s flu vaccine (CIDRAP)
Contract approved for utility plant to serve biodefense lab (Kansas City Star)
New device better traps viruses, airborne pathogens (Washington University)
3rd Intelligence Battalion sharpens CBRN skills (DVIDS)
Biological warfare biggest threat to world today (Indian Express)
Although well-adapted, novel coronavirus susceptible to immunotherapy (ASM)
Influenza vaccine efficacy: as low as 31%? (Clinicians’ Biosecurity Network)
Stash of stem cells found in a human parasite (HHMI News)
Defusing the threat of ionizing radiation (HSNW)
Los Angeles health officials concerned about TB outbreak (Reuters)
FDA expert: Universal flu vaccine still 5-10 years off (CIDRAP)
Quintiles files with SEC to become public company (AP)
Ancient teeth bacteria record disease evolution (University of Adelaide)